Abstract
A survey was carried out among EBMT (European Group for Blood and Marrow Transplantation) centres of the practical details of the prophylaxis and treatment of acute GVHD. The emphasis was on the prophylactic use of cyclosporine A and methotrexate and their combination, and on the initial treatment of acute GVHD. Eighty-seven centres sent a report. This survey demonstrated that marked differences exist between centres in the practices of GVHD prophylaxis and treatment despite superficially similar protocols. These differences may have an impact on the results obtained.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Adrenal Cortex Hormones / therapeutic use
-
Bone Marrow Transplantation / adverse effects*
-
Clinical Protocols
-
Cyclosporine / therapeutic use
-
Europa
-
Graft vs Host Disease / drug therapy*
-
Graft vs Host Disease / etiology
-
Graft vs Host Disease / prevention & control*
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Methotrexate / therapeutic use
-
Surveys and Questionnaires
-
Transplantation, Homologous
Substances
-
Adrenal Cortex Hormones
-
Immunosuppressive Agents
-
Cyclosporine
-
Methotrexate